The role of top2A and erb-B2 in breast cancer is well-known; top2A is an enzyme that catalyzes functions in DNA replication and is a molecular target for many anti-cancer drugs (topo2 inhibitors); erb-B2 is amplified frequently in breast cancer and is an independent prognostic target. The gene discussed is TOP2A; the disease is breast carcinoma.